1-14 of 14
Sanjay Mohan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from the Randomized, Multicenter, Global Phase 3 BOREAS Study: Navtemadlin Versus Best Available Therapy in JAK Inhibitor Relapsed / Refractory Myelofibrosis

John O. Mascarenhas, Viola Maria Popov, Sanjay Mohan, Zübeyde Nur Özkurt, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Andrew Perkins, Zhuying Huang, Hope Qamoos, Jesse McGreivy, Wayne Rothbaum, Srdan Verstovsek, Maciej Kaźmierczak
Journal: Blood
Blood (2024) 144 (Supplement 1): 1000.
https://doi.org/10.1182/blood-2024-201642
Published: 2024
Journal Articles

Impact of Co-Mutations, Monocytic Differentiation, and Choice of Hypomethylating Agent Combined with Venetoclax on the Predictive Value of Molecular Prognostic Risk Signature in Newly Diagnosed AML Patients

Kateryna Fedorov, Somedeb Ball, James E Denney, Alexis R Froenlich, Ashwin Kishtagari, Sanjay Mohan, Michael R. Savona, Emily F. Mason
Journal: Blood
Blood (2024) 144 (Supplement 1): 1474.
https://doi.org/10.1182/blood-2024-194259
Published: 2024
Journal Articles

Dose Escalation of ISB 1342, a Novel CD38xCD3 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Prashant Kapoor, Don A. Stevens, Xavier Leleu, Karim Belhadj Merzoug, Lionel Karlin, Salomon Manier, Thomas Chalopin, Cyrille Hulin, Aurore Perrot, Jésus G Berdeja, Cristiana Costa Chase, Cyrille Touzeau, Philippe Moreau, Sanjay Mohan, Alexander Lesokhin, Carol Huff, David H. Vesole, Joshua Richter, Jeffrey Matous, Eileen Wolff, Tejas Shah, Jeppe Koch-Olsen, Andrew Garton, Vinu Menon, Sunitha Gn, Mario Perro, Eugene Zhukovsky, Cyril Konto, Lida Pacaud, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 3339.
https://doi.org/10.1182/blood-2023-186664
Published: 2023
Journal Articles

Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Patients with Myelofibrosis: Long Term Follow up from XPORT-MF-034 Suggestive of Disease Modification

Srinivas K. Tantravahi, Ashwin Kishtagari, Keri Maher, Sanjay Mohan, Josef T. Prchal, Xulong Wang, Kamal Chamoun, Christopher J Walker, Pietro Taverna, Haris Ali
Journal: Blood
Blood (2023) 142 (Supplement 1): 622.
https://doi.org/10.1182/blood-2023-180844
Published: 2023
Journal Articles

Flat Dose Intravenous Immunoglobulin Primary Infection Prophylaxis in Multiple Myeloma Patients on Bispecific Antibody Therapy: Vanderbilt Experience

Naimisha Marneni, Bhagirathbhai Dholaria, Salyka Sengsayadeth, Eden Ayele Biltibo, Vivek Patel, Shakthi Bhaskar, Reena Jayani, Jill Gilbert, Jordan Berlin, Ashwin Kishtagari, Sanjay Mohan, David Morgan, Olalekan O. Oluwole, Bipin N. Savani, Adetola A. Kassim, Muhamed Baljevic
Journal: Blood
Blood (2023) 142 (Supplement 1): 3778.
https://doi.org/10.1182/blood-2023-190749
Published: 2023
Journal Articles

Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) As Monotherapy or with Ruxolitinib in Patients with Anemia Due to Myelofibrosis

Sanjay Mohan, Stephen Oh, Jean-Jacques Kiladjian, Masahiro Takeuchi, Jason Gotlib, Ellen K. Ritchie, Taizo Shimomura, Paola Guglielmelli, Anthony M. Hunter, Francesca Palandri, Francoise Boyer, Alessandro Rambaldi, Takehiko Mori, Tomoki Ito, Betty Lamothe, Yan-Ou Yang, Yi Cui, Francis Seguy, Amanda McBride, Prithviraj Bose
Journal: Blood
Blood (2023) 142 (Supplement 1): 624.
https://doi.org/10.1182/blood-2023-179291
Published: 2023
Journal Articles

Clonal Hematopoiesis and Inflammation in the Vasculature (CHIVE), a Prospective, Longitudinal Clonal Hematopoiesis Cohort and Biorepository

Jonathan Heimlich, Morgan Shannon, Sydney Olson, Alexander J Silver, Ariana Debevec, Zachary Copeland, Caitlyn Vlasschaert, Christina Snider, Ashwin Kishtagari, Donovan J Brown, Travis Spaulding, Manasa R Bhatta, Kelly Pugh, Shannon S Stockton, Jessica Ulloa, Yaomin Xu, Muhamed Baljevic, Sanjay Mohan, Javid J. Moslehi, Eiman Jahangir, Brent Ferrell, Jr., David Slosky, Alexander G. Bick, Michael R. Savona
Journal: Blood
Blood (2023) 142 (Supplement 1): 5594.
https://doi.org/10.1182/blood-2023-189808
Published: 2023
Journal Articles

A Phase 1/2 Study of INCB000928 As Monotherapy or in Combination with Ruxolitinib in Patients with Anemia Due to Myelofibrosis (INCB 00928-104)

Stephen T. Oh, MD, Jason Gotlib, MD MS, Sanjay Mohan, MD MSCI, Haris Ali, MD, Ekatherine Asatiani, MD, Francis Seguy, Feng Zhou, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-134574
Published: 2020
Journal Articles

miRNA Predictors of Response to DNA Methyltransferase Inhibitors

Amma Bosompem, MS, Yan Guo, PhD, Sanjay Mohan, MD, Begum Erdogan, MA, Muhammad Raza, MD, C. Michael Jones, MD FACP, Elizabeth A. Griffiths, MD, Annette S. Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1913.
https://doi.org/10.1182/blood.V124.21.1913.1913
Published: 2014
Journal Articles

A Suppressive Microenvironment in Acute Myeloid Leukemia Induces Global Alteration of T and NK Cell Profiles - Evidence for Immune-Editing Effect By Leukemia

Sawa Ito, MD, John Barrett, MD, Bipin N. Savani, MD, Madan Jagasia, MBBS, MS, Eolia Brissot, Samantha Miner, Nancy F. Hensel, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Minoo Battiwalla, MD MS, Michael R Savona, MD, Sanjay Mohan, MD, Mattias Carlsten, MD PhD, Pawel Muranski, MD, Stephen A. Strickland, MD MSCI
Journal: Blood
Blood (2014) 124 (21): 1047.
https://doi.org/10.1182/blood.V124.21.1047.1047
Published: 2014
Journal Articles

Impact of Myocardial Infarction On Survival in Acute Myeloid Leukemia

Joshua Lukenbill, D.O., Paul Elson, Sanjay Mohan, MD, Ramon V. Tiu, MD, Yogen Saunthararajah, MD, Leslie Farhat, Cassandra Kendeigh, Anjali Advani, MD, Edward A. Copelan, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2012) 120 (21): 4321.
https://doi.org/10.1182/blood.V120.21.4321.4321
Published: 2012
Journal Articles

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

Ying Jiang, Andrew Dunbar, Lukasz P. Gondek, Sanjay Mohan, Manjot Rataul, Christine O'Keefe, Mikkael Sekeres, Yogen Saunthararajah, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2009) 113 (6): 1315–1325.
https://doi.org/10.1182/blood-2008-06-163246
Published: 2009
Journal Articles

SNP Karyotyping Can Detect Clonality of Stem Cell Compartment and Early Malignant Evolution in Aplastic Anemia

Marcin Wlodarski, Sanjay Mohan, Lukasz Gondek, Jungwon Huh, Michael Clemente, Ramon Tiu, Jaroslaw Maciejewski
Journal: Blood
Blood (2008) 112 (11): 443.
https://doi.org/10.1182/blood.V112.11.443.443
Published: 2008
Journal Articles

Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Jaroslaw P. Maciejewski, MD, PhD, Edward Copelan, MD, Mikkael A. Sekeres, MD
Journal: Blood
Blood (2007) 110 (11): 4292.
https://doi.org/10.1182/blood.V110.11.4292.4292
Published: 2007